Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
Crossref DOI link: https://doi.org/10.1007/s12185-017-2386-y
Published Online: 2017-12-12
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Matsuoka, Ken-ichi
License valid from 2017-12-12